Literature DB >> 1386549

T gamma delta cells and their subsets in blood and synovial fluid from patients with rheumatoid arthritis.

C Lunardi1, C Marguerie, M J Walport, A K So.   

Abstract

We have determined the distribution of T gamma delta cells in the peripheral blood of 44 patients with rheumatoid arthritis and in 36 healthy controls. In addition, paired blood and synovial fluid samples were obtained from seven patients with RA. The monoclonal antibodies A13, BB3 and Ti gamma A, which are specific for the V delta 1, V delta 2 and V gamma 9 gene products respectively, were used to define T gamma delta subsets. T gamma delta + cells expressed as a percentage of CD3+ lymphocytes were reduced in RA peripheral blood compared with the control group (3.9% +/- 0.5 versus 5.7% +/- 0.7; P less than 0.0001). There was a reduction in the V gamma 9/V delta 2+ subset (from 5.6% +/- 1.2 to 1.7% +/- 0.4) leading to a change in the mean ratio of V delta 2/V delta 1+ cells from 4.3 in normal subjects to 1.1 (P less than 0.002). No statistical difference was observed in T gamma delta cell numbers in synovial fluid compared with the paired blood samples (4.0% +/- 1.1 in blood and 4.4% +/- 1.4 in synovial fluid). Also the distribution of V delta 2+ and V delta 1+ cells was similar in the two compartments and a similar alteration in subset distribution was found in blood and synovial fluid. These findings do not indicate a selective accumulation of a specific T gamma delta subset in RA synovial effusions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1386549     DOI: 10.1093/rheumatology/31.8.527

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  8 in total

Review 1.  Quantitative peripheral blood perturbations of γδ T cells in human disease and their clinical implications.

Authors:  Ilan Bank; Victoria Marcu-Malina
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

2.  Decreased expression of FcgammaRIII (CD16) by gammadelta T cells in patients with rheumatoid arthritis.

Authors:  M D Bodman-Smith; A Anand; V Durand; P Y Youinou; P M Lydyard
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

3.  gammadelta T cell subsets in patients with arthritis and chronic neutropenia.

Authors:  I Bank; L Cohen; M Mouallem; Z Farfel; E Grossman; A Ben-Nun
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

4.  Immune-mediated syndromes following intravenous bisphosphonate therapy.

Authors:  Noa Markovits; Ronen Loebstein; Ilan Bank
Journal:  Inflammopharmacology       Date:  2017-05-31       Impact factor: 4.473

5.  Potential regulatory role of in vitro-expanded Vδ1 T cells from human peripheral blood.

Authors:  Fang Hua; Ning Kang; Yun-An Gao; Lian-Xian Cui; De-Nian Ba; Wei He
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

Review 6.  T-cell antigen receptors in rheumatoid arthritis.

Authors:  L I Sakkas; P F Chen; C D Platsoucas
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

7.  Synergistic effects of ethanol and isopentenyl pyrophosphate on expansion of γδ T cells in synovial fluid from patients with arthritis.

Authors:  Agneta J Laurent; Niels Bindslev; Björn Johansson; Louise Berg
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

8.  Reduced pro-inflammatory profile of γδT cells in pregnant patients with rheumatoid arthritis.

Authors:  Manuela Tham; Gabriele R Schlör; Daniel Yerly; Christina Mueller; Daniel Surbek; Peter M Villiger; Frauke Förger
Journal:  Arthritis Res Ther       Date:  2016-01-22       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.